Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

[This corrects the article DOI: 10.1371/journal.pone.0121207.].

Bibliographic Details
Main Authors: Young-Ho Lee, Xiyong Liu, Fuming Qiu, Timothy R O'Connor, Yun Yen, David K Ann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4395453?pdf=render

Internet

http://europepmc.org/articles/PMC4395453?pdf=render

Similar Items